Perindopril

Also known as: Perindopril arginine

Active ingredient description

Perindopril is an inhibitor of the enzyme that converts angiotensin I into angiotensin II (Angiotensin Converting Enzyme ACE). The converting enzyme, or kinase, is an exopeptidase that allows conversion of angiotensin I into the vasoconstrictor angiotensin II as well as causing the degradation of the vasodilator bradykinin into an inactive heptapeptide. Inhibition of ACE results in a reduction of angiotensin II in the plasma, which leads to increased plasma renin activity (by inhibition of the negative feedback of renin release) and reduced secretion of aldosterone. Since ACE inactivates bradykinin, inhibition of ACE also results in an increased activity of circulating and local kallikrein-kinin systems (and thus also activation of the prostaglandin system).

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Perindopril
C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA04

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Medicines

Perindopril is the active ingredient of these drugs:

Drug
Countries

South Africa

Turkey

Brazil Hong Kong

South Africa

Poland

South Africa

Tunisia

South Africa

South Africa

South Africa

Spain

Austria

Australia Brazil Cyprus Ecuador Finland

Hong Kong

Poland

Romania

Singapore

Australia

Australia

Austria

Turkey

South Africa

South Africa

Ireland

Turkey

Singapore

Hong Kong

Poland

Australia Germany

Lithuania

Estonia Lithuania

Hong Kong

South Africa

Turkey

Estonia Lithuania Poland Romania

Poland

Estonia Lithuania Poland Romania

Australia South Africa

Romania

Italy

Hong Kong Singapore

Turkey

South Africa

South Africa

Turkey

Estonia Lithuania Poland

Tunisia

Romania

South Africa

South Africa

Poland

Perindopril is also found within below combination drugs:

ACEPER PLUS , ACERTALIX , ACERTANLO , ACERTIL PLUS , ACERYCAL , ACTI-PREX PLUS , AMLESSA , AMLESSINI , AMLOPER , ARPLEXAM , BEATIL , BI-THERAPRIL , BIPRETERAX , BOTINERO , CIPLASYL PLUS , CIRCATOR PLUS , CO-AMLESSA , CO-DALNESSA , CO-PERINDALON , CO-PERINEVA , CO-PRENESSA , CO-PRESOMYL , CO-PRESTARIUM , CO-THERAPRIL , COPRENESSA , COSIMPREL , COSYREL , COVERAM , COVERDINE , COVERLAM , COVERON PLUS , COVERSYL COMP , COVERSYL PLUS , DALNESSA , DALNEVA , DANURIT , EUVASCOR , FLAMIPAX , IDAPREX COMBI , INDIX COMBI , INDOSYL COMBI , LIPERCOSYL , LIPERTANCE , LOPRIDAM , MIXANVAL , NOLIPREL , NOLITERAX , NORIPLEX , NORMOTRI , NORPLEXAM , PADERO PLUS , PANOPRIST , PARATERAX , PARVAXOR , PEARINDA PLUS , PENDREX PLUS , PERAM , PERDAPAX , PERDUO , PERIDAY PLUS , PERILEXIN , PERINDAP , PERINDO COMBI , PERIVEL PLUS , PERPRIL PLUS , PREAMLESSA , PREDONIUM , PRELECTAL , PRENEWEL , PRESTALIA , PRESTANCE , PRESTARIUM COMBI , PRESTERAM , PRESTILOL , PRESTOZEK COMBI , PRETERAX , PRETERVAL , PREXAREL , PREXUM COMBI , PREXUM PLUS , PRIAMLO , PRINDAL , RATEN PLUS , REAPTAN , ROSAMERA , ROXAMPEX , ROXIPER , SCALIANT , SERPERIL PLUS , TACERNOL , TAKAWITA , TERAXANS , TERTENSIF KOMBI , TONARSSA , TRIPLIAM , TRIPLIXAM , TRIVERAM , VECTORYL PLUS , VIACORAM , VIACORLIX , VIDONORM , VILPIN COMBI

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₁₉H₃₂N₂O₅
Molecular mass: 368.468 g/mol

External identifiers

CAS Substance: 82834-16-0
DrugBank Drug: DB00790
KEGG Drug: D03753
PubChem Compound: 107807
RxNorm Ingredient: 54552
SNOMED-CT Concept: 350606002
Perindopril (substance)
SNOMED-CT Concept: 372916001
Perindopril (substance)
UNII Identifier: Y5GMK36KGY
PERINDOPRIL